Group One Trading
JBIO

Group One Trading’s Jade Biosciences JBIO Stock Holding History

Group One Trading’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-23,889
Closed -$2.22M – 7570
2024
Q4 		$2.22M Buy
23,889
+23,112
+2,975% +$1.99M 0.01% 1821
2024
Q3 		$56.8K Buy
+777
New +$50.1K ﹤0.01% 4567

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Group One Trading's JBIO Position: Q1 2026 in Review

Group One Trading reduced its Jade Biosciences (JBIO) stake by 100% in Q1 2026, selling an estimated $60.7K and leaving 4 shares worth $56. The position accounts for ﹤0.01% of the portfolio, ranked #7447.

Group One Trading first reported a position in JBIO in Q2 2024 and has held it in 8 quarters since. The position peaked at $371K in Q4 2024. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

  • Group One Trading held 4 shares of Jade Biosciences worth $56 as of Q1 2026.
  • Group One Trading sold 4,191 Jade Biosciences shares in Q1 2026, an estimated $60.7K.
  • Jade Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7447 holding.
  • Group One Trading first reported a position in Jade Biosciences in Q2 2024 and has held it in 8 quarters since.
  • Group One Trading's Jade Biosciences position peaked at $371K in Q4 2024.
  • 120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.